Pharmacy and Therapeutics March 2017 : Cover 1

AMCP March 2017 Volume 42 Number 3 CONFERENCE ISSUE A Peer-Reviewed Journal for Managed Care and Formulary Management Decision-Makers Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting M. Barna Bridgeman, PharmD, BCPS, BCGP; and D. T. Abazia, PharmD, BCPS, CPE VISIT US ONLINE AT WWW.PTCOMMUNITY.COM Targeting Interleukin-5 in Patients With Severe Eosinophilic Asthma: A Clinical Review C. Lam, PharmD, BCPS; K. J. Shah, PharmD; and R. Mansukhani, PharmD An Evaluation of Selected Indications and Appropriateness of Ampicillin/Sulbactam, an Unrestricted Antimicrobial, at a Single Center D. McCoy, PharmD, BCPS-AQ ID; R. Sebti, MD; and A. G. Kuyumjian, PharmD FDA Revisits Rules on Drug And Device Communication Will the Agency Relax Industry-Opposed Restrictions? S. Barlas MEDICATION ERRORS A Mislabeling Event With Batched Drugs: The Unintended Consequences of Practice Changes M. Grissinger, RPh, FASCP DRUG FORECAST Rolapitant (Varubi) A Substance P/Neurokinin-1 Receptor Antagonist For the Prevention of Chemotherapy-Induced Nausea and Vomiting T. Goldberg, PharmD, BCPS; B. Fidler, PharmD; and S. Cardinale, PharmD MEETING HIGHLIGHTS American College of Rheumatology/ Association of Rheumatology Health Professionals Annual Meeting P. Sonnenreich, MA; and J. Jesitus, MA

Next Page

Publication List
Using a screen reader? Click Here